Free Trial
OTCMKTS:PXXLF

Poxel (PXXLF) Stock Price, News & Analysis

Poxel logo
$0.25 0.00 (0.00%)
As of 05/23/2025

About Poxel Stock (OTCMKTS:PXXLF)

Key Stats

Today's Range
$0.25
$0.25
50-Day Range
$0.25
$0.25
52-Week Range
$0.25
$0.25
Volume
N/A
Average Volume
N/A
Market Capitalization
$7.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial pyruvate carrier inhibitor, which is in a phase I clinical trial for the treatment of NASH. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.

Receive PXXLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Poxel and its competitors with MarketBeat's FREE daily newsletter.

PXXLF Stock News Headlines

Google Pixel 10: Ultimate Preview Guide
Elon’s 2025 Silver Crisis (What It Means for You)
Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless production of electric vehicles and solar technology is driving demand for the precious metal to unprecedented levels. Silver—critical for EV batteries, solar panels, and advanced electronics—is now at the center of a supply crisis.
See More Headlines

PXXLF Stock Analysis - Frequently Asked Questions

Poxel's stock was trading at $0.25 at the start of the year. Since then, PXXLF stock has increased by 0.0% and is now trading at $0.25.
View the best growth stocks for 2025 here
.

Shares of PXXLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:PXXLF
CIK
N/A
Employees
15
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$710,000.00
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$7.24 million
Optionable
Not Optionable
Beta
0.53
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:PXXLF) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners